课题基金 / 基金详情

MR Assessment of Bioenergetics and Microvascular Function in Dystrophic Muscle

MR Assessment of Bioenergetics and Microvascular Function in Dystrophic Muscle
营养不良性肌肉生物能学和微血管功能的 MR 评估
批准号:
9355463
负责人:
Sean C Forbes
金额:
$33.9万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-20 至 2021-07-31

项目摘要

项目成果

Sean C Forbes的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 本项目的总体目标是评估新型磁共振成像(MRI)的潜力, 局部31磷磁共振波谱(31 P-MRS)测量生物能量学, 微血管功能监测疾病进展和营养不良肌肉的治疗。Duchenne 肌营养不良症(DMD)的特征是进行性肌无力、功能恶化、 丧失独立性,过早死亡。DMD儿童的肌肉缺乏肌营养不良蛋白, 其伴随着肌膜定位的神经元型一氧化氮合酶(nNOS)的缺乏。虽然 DMD没有治愈的方法,一些有前途的治疗方法正在开发和评估中,年轻的 男孩主要是被作为实验对象。然而,疾病进展的可靠标志物是 缺乏,尤其是年轻人。最近的研究表明,在肌肉能量方面有相当大的希望, 用31 P-MRS测量的状态作为营养不良肌肉病理学的早期标志物。这些的原因 能量干扰(例如,减少磷酸肌酸)的理解很少,以及对 疾病进展和治疗。营养不良肌肉中神经型一氧化氮合酶(nNOS)的缺乏 已被归因于导致DMD中骨骼肌收缩期间和之后的血流量减少, 也可能有助于报告的能量扰动和增加的易感性, 营养不良的肌肉在目标1中,我们将使用鼠模型(mdx)来提供对 目的2:利用高分辨率MR研究营养不良患者的能量状态和微血管功能。 用具有和不具有nNOS结合的已建立的AAV-微肌营养不良蛋白载体处理的效果 域最后,在目标3中,我们将把这些方法应用于患有DMD和未受影响的男孩的下肢 使用横截面设计的年龄范围内的控制。MR测量将评价1) 利用31 P二维化学位移成像测量肌肉的能量状态; 2)利用MRI测量微血管功能 血氧水平依赖性(BOLD)对比和动脉自旋标记(ASL)。此外,我们将测试 DMD和对照组中这些指标的每日变化。这个项目的总体假设是, 生物能量学和微血管功能的局部MR测量将能够早期检测疾病 在年轻的时候,病理学,将对疾病进展作出反应,并将有效地监测 改善营养不良肌肉的治疗。我们预计,结果将导致可重复的 可用于评估针对DMD和其他神经肌肉疾病的潜在治疗方法 疾病
英文摘要
Project Summary The overall objective of this project is to evaluate the potential of novel magnetic resonance imaging (MRI) and localized 31phosphorus-magnetic resonance spectroscopy (31P-MRS) measures of bioenergetics and microvascular function to monitor disease progression and treatment in dystrophic muscle. Duchenne muscular dystrophy (DMD) is characterized by progressive muscle weakness, deteriorating functional capabilities, loss of independence, and early death. Muscles in children with DMD are deficient in dystrophin, which is accompanied by a lack of sarcolemma-localized neuronal nitric oxide synthase (nNOS). Although there is no cure for DMD, a number of promising therapies are being developed and evaluated, and young boys are predominantly being targeted as subjects. However, reliable markers of disease progression are lacking, particularly in young boys. Recent studies have shown considerable promise in muscle energetic status measured with 31P-MRS as an early marker of pathology in dystrophic muscle. The cause of these energetic disturbances (e.g., reduced phosphocreatine) is poorly understood, as well as the response to disease progression and treatment. The lack of neuronal nitric oxide synthase (nNOS) in dystrophic muscle has been attributed to cause reduced blood flow during and following skeletal muscle contractions in DMD, and may also contribute to the reported energetic perturbations and increased susceptibility to damage in dystrophic muscle. In aim 1 we will use a murine model (mdx) to provide insight into the relationship between energetic status and microvascular function in dystrophy using high resolution MR. In aim 2, we will establish the effects of treatment with an established AAV-microdystrophin vector with and without the nNOS binding domain. Finally, in aim 3, we will apply these methods to the lower extremity of boys with DMD and unaffected controls in a range of ages using a cross sectional design. MR measures will evaluate 1) heterogeneity of energetic status among muscles using 31P 2D chemical shift imaging and 2) microvascular function using MRI blood oxygenation-level dependent (BOLD) contrast and arterial spin labeling (ASL). Furthermore, we will test the day-to-day variability of these measures in DMD and controls. The overall hypothesis of this project is that localized MR measures of bioenergetics and microvascular function will enable early detection of disease pathology at a young age, will be responsive to disease progression, and will be effective in monitoring improvements with treatment in dystrophic muscle. We anticipate that the results will lead to reproducible methods that can be implemented to evaluate potential treatments targeted at DMD and other neuromuscular diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Magnetic resonance biomarkers of muscle degeneration in patients with rotator cuff tears
  • 批准号:
    10478830
  • 项目类别:
  • 资助金额:
    $19.93万
  • 财政年份:
    2021
  • 负责人:
    Sean C Forbes
  • 依托单位:
MR Assessment of Bioenergetics and Microvascular Function in Dystrophic Muscle
  • 批准号:
    9754775
  • 项目类别:
  • 资助金额:
    $33.59万
  • 财政年份:
    2016
  • 负责人:
    Sean C Forbes
  • 依托单位:
海外基金